Literature DB >> 11754181

Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy.

Guillaume Nicolas1, Thierry Maisonobe, Nadine Le Forestier, Jean-Marc Léger, Pierre Bouche.   

Abstract

Electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) were proposed by an Ad Hoc Subcommittee of the American Academy of Neurology (AAN) in 1991. Only 60% of CIDP patients fulfilled these criteria, which therefore appear poorly sensitive. We therefore sought to revise the electrophysiological criteria. We selected 40 CIDP patients and compared them with 35 patients with axonal polyneuropathy, 116 patients with Charcot-Marie-Tooth type 1A (CMT1A) disease, and 66 patients with immunoglobulin M (IgM) monoclonal gammopathy. The proposed electrophysiological criteria identified 90% of the CIDP patients, although 3% of patients with axonal polyneuropathy were falsely identified. For the CIDP patients, sensitivity and specificity were 90% and 97%, respectively. Of the patients with IgM monoclonal gammaglobulin of undetermined significance (MGUS) and CMT1A, 100% fulfilled these new criteria, whereas 90% and 97%, respectively, fulfilled the AAN criteria. These results suggest that the AAN criteria are more appropriate for IgM MGUS and CMT1A patients than for CIDP patients. We therefore propose new electrophysiological criteria for CIDP that appear to have better sensitivity. Copyright 2002 American Association of Electrodiagnostic Medicine

Entities:  

Mesh:

Year:  2002        PMID: 11754181     DOI: 10.1002/mus.1214

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  15 in total

Review 1.  Current concepts and controversy in chronic inflammatory demyelinating polyneuropathy.

Authors:  David S Saperstein; Richard J Barohn
Journal:  Curr Neurol Neurosci Rep       Date:  2003-01       Impact factor: 5.081

Review 2.  Management of chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Richard A C Hughes
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Chronic inflammatory demyelinating polyneuropathy and diabetes.

Authors:  Andrew J M Boulton
Journal:  Curr Diab Rep       Date:  2003-12       Impact factor: 4.810

4.  The diagnosis of chronic inflammatory demyelinating polyneuropathy: a Delphi-method approach.

Authors:  Alain Créange; Arnold Careyron
Journal:  J Neurol       Date:  2013-09-20       Impact factor: 4.849

5.  Electrophysiological predictors of steroid-responsiveness in chronic inflammatory demyelinating polyneuropathy.

Authors:  Y A Rajabally; M Narasimhan; G Chavada
Journal:  J Neurol       Date:  2008-04-30       Impact factor: 4.849

6.  Incidence and prevalence of CIDP and the association of diabetes mellitus.

Authors:  R S Laughlin; P J Dyck; L J Melton; C Leibson; J Ransom; P J B Dyck
Journal:  Neurology       Date:  2009-07-07       Impact factor: 9.910

Review 7.  Advances in the diagnosis, pathogenesis and treatment of CIDP.

Authors:  Marinos C Dalakas
Journal:  Nat Rev Neurol       Date:  2011-08-16       Impact factor: 42.937

Review 8.  Chronic inflammatory demyelinating polyneuropathies: current treatment strategies.

Authors:  Thomas B Toothaker; Thomas H Brannagan
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

Review 9.  Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.

Authors:  Michael Pt Lunn; Eduardo Nobile-Orazio
Journal:  Cochrane Database Syst Rev       Date:  2016-10-04

10.  Diagnosing chronic inflammatory demyelinating polyradiculoneuropathy with triple stimulation technique.

Authors:  Du Cao; Xiuming Guo; Ting Yuan; Jie Hao
Journal:  J Neurol       Date:  2018-06-20       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.